Search

everythinglearnresearchcommunity

for

Search:↓

Glypican-4 may help indicate insulin sensitivity and lipid issues in women with PCOS.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

Effective PCOS treatments require targeting specific signaling pathways.

Over 40% of postmenopausal women experience hair loss, with treatments aiming to stop further loss and possibly thicken hair.

Most women with excess male hormones have Polycystic Ovary Syndrome, and hormonal therapy can improve symptoms but may cause side effects.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

The document concludes that accurate diagnosis of ichthyosis is crucial for treatment and genetic advice, and ongoing research is needed for better therapies.

Oral spironolactone's effectiveness for adult female acne is not well-supported by strong evidence.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

The conclusion is that there is a high demand for new contraceptives that provide both pregnancy prevention and protection against STIs, along with additional health benefits.

PCOS is a long-term condition that needs more research for better understanding and treatment.

Normal-range ALT levels can indicate metabolic and hormonal imbalances in young women.

The document concludes that early diagnosis and treatment of PCOS in teenagers is important for managing symptoms and preventing long-term health problems.

Androgens like testosterone affect skin health and can lead to conditions such as acne and hair loss, with various treatments available.

The conclusion suggests that PCOS may persist due to genetic traits that, while harmful for female fertility, could have provided survival and reproductive benefits to males.

High fasting insulin levels in women with PCOS are linked to a higher risk of heart and metabolic problems.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

Fetal environments contain various chemicals that may disrupt hormones.

Chemicals and body size might change when puberty starts and progresses, but more research is needed to confirm this.

Estrogens significantly influence hair growth by interacting with receptors in hair follicles and may help regulate the hair growth cycle.

Skin changes can help diagnose and manage endocrine disorders like thyroid problems, diabetes, and adrenal gland conditions.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Hormonal contraceptives can help treat acne by affecting sebum production and androgen levels.

Etlingera alba extract may help treat breast cancer with fewer side effects.

Insulin resistance is strongly linked to higher androgen levels in women with PCOS.

The vitamin D receptor is crucial for bone health and affects various body systems, with mutations potentially leading to disease.

Cushing's syndrome can cause serious health problems, and early treatment is crucial, but some issues may remain after treatment.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

Creating stronger blockers for skin enzymes might lead to better treatment for conditions like acne and excessive hair growth.

Estrogens can improve skin aging but carry risks; more research is needed on safer treatments.